Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e67081
Publisher
Public Library of Science (PLoS)
Online
2013-06-12
DOI
10.1371/journal.pone.0067081
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
- (2012) Daniel A. Monti et al. PLoS One
- Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic Discoveries
- (2012) Mark Levine et al. Advances in Nutrition
- Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells
- (2011) Sung-Ho An et al. BMB Reports
- Vitamins C and E: Beneficial effects from a mechanistic perspective
- (2011) Maret G. Traber et al. FREE RADICAL BIOLOGY AND MEDICINE
- Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models
- (2011) Ping Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
- (2011) Michael Graham Espey et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin
- (2011) Lauren J. Akers et al. LEUKEMIA RESEARCH
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacologic Doses of Ascorbic Acid Repress Specificity Protein (Sp) Transcription Factors and Sp-Regulated Genes in Colon Cancer Cells
- (2011) Satya S. Pathi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect
- (2011) Minsuh Seo et al. PLoS One
- Targeting Glucose Metabolism
- (2010) Brijesh M. Madhok et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Selective Ascorbate Toxicity in Malignant Mesothelioma
- (2010) Elia Ranzato et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
- (2010) J. Du et al. CLINICAL CANCER RESEARCH
- The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma
- (2010) Alejandro G. Levy et al. INVESTIGATIONAL NEW DRUGS
- Combined arginine and ascorbic acid treatment induces apoptosis in the hepatoma cell line HA22T/VGH and changes in redox status involving the pentose phosphate pathway and reactive oxygen and nitrogen species☆
- (2010) Bau-Shan Hsieh et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
- (2010) Sebastian J. Padayatty et al. PLoS One
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- Vitamin C: update on physiology and pharmacology
- (2009) J Mandl et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ascorbic Acid and Gene Expression: Another Example of Regulation of Gene Expression by Small Molecules?
- (2009) Sophie Belin et al. CURRENT GENOMICS
- Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
- (2009) Julien Verrax et al. FREE RADICAL BIOLOGY AND MEDICINE
- Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatment
- (2009) Mark Levine et al. FREE RADICAL BIOLOGY AND MEDICINE
- High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis
- (2009) Chang-Hwan Yeom et al. Journal of Translational Medicine
- Antiproliferative Effect of Ascorbic Acid Is Associated with the Inhibition of Genes Necessary to Cell Cycle Progression
- (2009) Sophie Belin et al. PLoS One
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor
- (2008) Yu Mi Ha et al. CANCER LETTERS
- Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs
- (2008) M. L. Heaney et al. CANCER RESEARCH
- Glycolytic enzyme inhibitors in cancer treatment
- (2008) Roberto Scatena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
- (2008) B. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
- (2008) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started